Functional assessment of coronary stenoses: Can we live without it?

European Heart Journal

Volumn 34, Issue 18, 2013, Pages 1335-1344

  Pijls, Nico H J ^a,b   Tanaka, Nobuhiro ^c   Fearon, William F ^d  

^a CATHARINA HOSPITAL   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Coronary artery stenosis; Fractional flow reserve; Functional assessment; Pressure wire

Indexed keywords

ACUTE HEART INFARCTION; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOPLASTY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; EXERCISE TEST; FOLLOW UP; FRACTIONAL FLOW RESERVE; FUNCTIONAL ASSESSMENT; GUIDING CATHETER; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INVASIVE PROCEDURE; ISCHEMIC HEART DISEASE; LONGEVITY; MEDICAL DECISION MAKING; NON INVASIVE PROCEDURE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEADY STATE; SURVIVAL;

CORONARY ARTERY STENOSIS; FRACTIONAL FLOW RESERVE; FUNCTIONAL ASSESSMENT; PRESSURE WIRE;

CARDIAC CATHETERIZATION; CLINICAL TRIALS AS TOPIC; CORONARY STENOSIS; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PROGNOSIS;

EID: 84877746159     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs436     Document Type: Review

References (35)

1. Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikena F, Van 't Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, McCarthy PA, Fearon WF. Fractional Flow Reserve versus angiography for guiding PCI in patients with multivessel coronary disease (FAME study). N Engl J Med 2009;360:213-224
2. Gruentzig AR, Senning A, Siegenthaler WE. Non-operative dilatation of coronary artery stenoses. N Engl J Med 1979;301:61-68
3. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;49:2105-2111
4. Shaw LJ, Heller GV, Casperson P, Miranda-Peats R, Slomka P, Friedman J, Hayes SW, Schwartz R, Weintraub WS, Maron DJ, Dada M, King S, Teo K, Hartigan P, Boden WE, O'Rourke RA, Berman DS. Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no 424. J Nucl Cardiol 2006;13:685-698
5. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, Van Den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-972
6. Davies RF, Goldberg AD, Forman S. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up; outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037-2043
7. Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, van't Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, Maccarthy PA, De Bruyne B. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010;56:177-184
8. Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: A randomized trial. Circulation 2001;103:2928-2934
9. Pijls NHJ, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't Veer M, Ba¨r F, Hoorntje J, Koolen J, Wijns W, De Bruyne B. Percutaneous coronary intervention of functionally non-significant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007;49:2105-2111
10. Hachimovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-2906
11. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW. A prospective study natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-235
12. Wijns W, Kojl Ph, on behalf of the Joint Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association of Cardiac-Thoracic Surgery (EACTS). Guidelines on myocardial revascularization. Euro Heart J 2010;31:2501-2555
13. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;87:1354-1367
14. Pijls NHJ, De Bruyne B, Peels K, Vande Voort P, Bartunek J, Bonnier H, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. N Engl J Med 1996;334:1703-1708
15. De Bruyne B, Pijls NHJ, Barbato E et al. Intracoronary and intravenous adenosine 50-triphosphate, papaverine, and contrastmedium to assess factional flow reserve in humans. Circulation 2003;107:1877-1883
16. De Bruyne B, Pijls NHJ, Bartunek J, Kulecki K, Bech JW, De Winter H, Van Crombrugge P, Heyndrickx GR, Wijns W. Fractional flow reserve in patients with prior myocardial infarction. Circulation 2001;14:157-162
17. Koolen JJ, Pijls NHJ. Coronary Pressure Never Lies. Cathet Cardiov Interv 2008;72: 248-256
18. Pijls NHJ. Optimum guidance of complex PCI by coronary pressure measurement. Heart 2004;90:1085-1093
19. DiMario C, Heyndrickx GR, Prati F, Pijls NHJ. Invasive imaging and hemodynamics: Functional assessment of the coronary circulation. In Camm AJ, Luescher TF, Serruys PW (eds), The ESC Textbook of Cardiovascular Medicine, 2nd edn. New York: Oxford University Press; 2009. pp. 267-279
20. Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G et al. Longterm clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation 2009;120:1505-1512
21. Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J, Heyndrickx GR, Pijls NH, De Bruyne B. Long-term clinical outcome after fractional flow reserveguided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 2005;46:438-442
22. Lima RSL, Watson DD, Goode AR, Siadaty MS, Ragosta M, Beller GA, Samady H. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol 2003;42:64-70
23. De Bruyne B, Hersbach F, Pijls NHJ, Bartunek J, Bech JW, Heyndrickx GR, Gould KL, Wijns W. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but 'normal' coronary angiography. Circulation 2001;104: 2401-2406
24. Fearon WF, Bornschein B, Tonino PAL, Gothe RM, De Bruyne B, Pijls NHJ, Siebert U. Economic evaluation of fractional flow reserve guided percutaneous coronary intervention patients with multivessel disease. Circulation 2010;122: 2545-2550
25. Leesar MA, Mintz GS. Hemodynamic and intravascular ultrasound assessment of an ambiguous left main coronary artery stenosis. Catheter Cardiovasc Interv 2007; 70:721-730
26. Lindstaedt M, Spiecker M, Perings C, Lawo T, Yazar A, Holland-Letz T, Muegge A, Bojara W, Bojara W, Germing A. How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses?. Int J Cardiol 2007;120:254-261
27. Wongpraparut N, Yalamanchili V, Pasnoori V, Satran A, Chandra M, Masden R, Leesar MA. Thirty-month outcome after fractional flow reserve-guided versus conventional multivessel percutaneous coronary intervention. Am J Cardiol 2005;96:877-884
28. Ahn JM, Lee JY, Kang SJ, Kim YH, Song HG, Oh JH, Park JS, Kim WJ, Lee SW, Lee CW, Kim JJ, Park SW, Park SJ. Functional assessment of jailed side branches in coronary bifurcation lesions using fractional flow reserve. JACC Cardiovasc Interv 2012; 5:155-161
29. Sels JW, Tonino PAL, Siebert U, Fearon WF, Van't Veer M, De Bruyne B, Pijls NHJ. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus. Angiography for Multivessel Evaluation) study. JACC Cardiovasc Interv 2011;4:1183-1189
30. Nam CW, Mangiacapra F, Entjes R, Chung IS, De Bruyne B, Siebert U, Sels JW, Pijls NHJ, Fearon WF. The fractional flow reserve guided SYNTAX Score for risk assessment in multivessel coronary artery disease. JACC 2011;58:1211-1218
31. Sant'Anna FM, Silva EE, Batista LA, Ventura FM, Barrozo GA, Pijls NHJ. Influence of routine measurement of fractional flow reserve on decision making during coronary intervention. Am J Cardiol 2007;99:504-508
32. Tonino PAL, Fearon WF, De Bruyne B, Oldroyd KG, Leesar M, Ver Lee PN, MacCarthy PA, Van't Veer M, Pijls NHJ. Angiographic versus functional severity of coronary artery stenoses in the FAME study. J Am Coll Cardiol 2010;55: 2816-2821
33. Ntalianis A, Sels JW, Davidavicius G, Tanaka N, Muller O, Trana C, Barbato E, Hamilos M, Mangiacapra F, Heyndrickx GR, Wijns W, Pijls NHJ, De Bruyne B. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv 2010;3: 1274-1281
34. Nair PK, Marroquin OC, Mulukutla SR, Khandar S, Gulati V, Schindler JT, Lee JS. Clinical utility of regadenoson for assessing fractional flow reserve. JACC Cardiovasc Interv 2011;4:1085-1092
35. Pijls NHJ, Tonino PAL. The crux of maximum hyperemia: The last remaining barrier for routine use of fractional flow reserve. JACC Cardiovasc Interv 2011;4: 1093-1095